3EO Health licenses Wyss Institute technology from Harvard,

The technology fills a present gap in diagnostic testing and could contribute to extending the four walls of the health system for COVID-19 and beyond...

Related Keywords

Boston University ,Massachusetts ,United States ,University Of Massachusetts Medical School ,Massachusetts Institute Of Technology ,Harvard University ,Boston ,Tufts University ,Berlin ,Germany ,Spaulding Rehabilitation Hospital ,Nikhil Gopalkrishnan ,Jeremy Schubert ,Jiyoun Jeong ,Thomas Schaus ,Donald Ingber ,Benjamin Boettner ,Beth Israel Deaconess Medical Center ,Wys Molecular Robotics Initiative ,Spear Bio Inc ,Ultivue Inc ,Wyss Institute ,Deo Health ,Wyss Molecular Robotics Initiative ,Harvard Office Of Technology Development ,Harvard Johna Paulson School Of Engineering ,Digital Biology Inc ,Farber Cancer Institute ,Arts Sciences ,Technology Access Framework ,Harvard University Office Of Technology Development ,Eo Health Inc ,Sciences Engineering Accelerator ,Torus Biosystems Inc ,Biologically Inspired Engineering ,Technology Development ,Wyss Core Faculty ,Peng Yin ,Core Faculty ,Systems Biology ,Harvard Medical School ,Nuprobe Global ,Senior Scientist ,Staff Lead ,Wyss Founding Director ,Judah Folkman Professor ,Vascular Biology ,Boston Children ,Wyss Professor ,Bioinspired Engineering ,Harvard John ,Massachusetts General Hospital ,Massachusetts Medical School ,Massachusetts Institute ,Blavatnik Biomedical Accelerator ,Physical Sciences ,Wyss Institute At Harvard University ,